Use of recombinant factor VIII (8) concentrates in Haemophilia A

Published: 25 November 2024

The purpose of this guideline is to provide clinical advice around the use of recombinant factor VIII (8) in paediatric patients under the care of Queensland Children’s Hospital (QCH).

Files

Thumbnail of Use of recombinant factor VIII (8) concentrates in Haemophilia A
  • Audience Health professionals; Staff
  • FormatDocument
  • Information typeStandards and guidelines
  • LanguageEnglish
  • Last updated25 November 2024

Topics